We harness the power of artificial intelligence, advanced wet lab techniques and expert creativity to transform areas of significant value in biologics discovery and engineering.
AI-designed large-scale GPCR mutagenesis to deliver the best antigen for antibody discovery
Enabling rapid antibody discovery in the untapped GPCR target space
Rounds of Optimization
Variants Expressed
Weeks
Increased in Affinity
Parental 1.53E -7 (M)
Ab-Ag complex structure from primary sequences
In silico
25 residues identified at the Ab-Ag interface from XtalFold™ structure
In silico
LLM Trained On Proteins
In silico
Recommended mutants that are developable
In silico
Rank all mutants by predicted KD
In silico
Rank all mutants by predicted KD
In silico
11 single point mutations predicted to increase affinity
In silico
Wet lab data feeds back & optimizes AI model
In silico
Cell-free expression & BLI
In vitro
CHO expression & BLI/SPR
In vitro
Top clone 1.53E-9 (M) 5 pt mutations
AI-powered hit selection and amplification from immune repertoire sequencing
Rounds
Expressed
Function Hits
Activity Span
Weeks
Integrates fully with conventional discovery and engineering
The future of biotechnology is collaborative. We believe the best solutions come from working together with companies and researchers who share our vision. Are you ready to push the boundaries of what’s possible?
© 2024 Ailux Biologics. All rights reserved.